AtriCure (ATRC) Metrics: History & Chart

AtriCure, Inc.(ATRC)

Medical - Instruments & Supplies · Mason, OH

$54.90-1.47 (-2.61%)

Delayed quote: Oct 6, 2026, 12:10 PM EDT

About AtriCure, Inc.

AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-use radiofrequency products. Its multifunctional pens, such as the MAX Pen, uniquely enable surgeons to evaluate cardiac arrhythmias, conduct temporary pacing, sensing, and stimulation, and perform tissue ablation with a single device. The Coolrail device facilitates the creation of longer linear ablation lines. For varying lengths of linear ablations, the CryoICE Cryoablation System is available. Furthermore, the EPi-Sense Guided Coagulation System is a single-use solution for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. AtriCure also provides systems for cardiac appendage management and soft-tissue closure. The AtriClip System is an implantable device accompanied by a disposable applier, while the LARIAT System offers a suture-based solution for soft-tissue closure, compatible with various anatomical shapes. Additionally, AtriCure offers supplementary surgical tools including Lumitip Dissectors, designed to separate tissues for optimal access, Glidepath guides for precise clamp placement, and Subtle Cannulas facilitating access for EPi-Sense catheters. A suite of reusable cardiac surgery instruments, crucial for procedures involving heart valve repair or replacement, is also available. The company distributes its offerings through a combination of independent distributors and direct sales personnel. Founded in 2000, AtriCure maintains its headquarters in Mason, Ohio.

Mason, OH

1,350 employees

www.atricure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Michael H. Carrel

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-3.49%
30D Total Return	+9.41%
YTD Total Return	+42.49%
1Y Total Return	+61.94%
3Y Total Return	+37.22%
5Y Total Return	-18.71%
10Y Total Return	+252.85%
15Y Total Return	+437.23%
20Y Total Return	+662.37%

2026	+42.49%
2025	+29.45%
2024	-14.37%
2023	-19.58%
2022	-36.17%
2021	+24.90%
2020

CAGR TTM	+61.56%
CAGR 3Y	+11.12%
CAGR 5Y	-4.06%
CAGR 10Y	+13.44%
CAGR 15Y	+11.86%
CAGR 20Y	+10.69%

PE Ratio	265.65
PE Ratio Avg TTM	234.61
PE Ratio Avg 3Y	234.61
Current VS TTM Avg	+13.23%
Current VS 3Y Avg	+13.23%
Current VS 5Y Avg	+411.96%

All Metrics

ATRC Valuation Metrics

ATRC Stock Price Metrics

ATRC Dividend Metrics

ATRC Growth Rate Metrics

ATRC Discounted Cash Flow Metrics

ATRC Returns By Period

ATRC Yearly Returns

ATRC Average Annual Returns By Period (CAGR)

ATRC Revenue Metrics

ATRC PE Ratio Metrics

ATRC PS Ratio Metrics

ATRC PB Ratio Metrics

ATRC Price to Free Cash Flow Ratio Metrics

ATRC Debt to Equity Ratio Metrics

ATRC PEG Ratio Metrics

ATRC FCF Yield

ATRC Earnings Yield

ATRC EBITDA Yield

ATRC OCF Yield

ATRC EV/EBIT Ratio Metrics

ATRC EV/EBITDA Ratio Metrics

ATRC EV/Assets Ratio Metrics

ATRC EV/Sales Ratio Metrics

ATRC Current Ratio Metrics

ATRC Quick Ratio Metrics

ATRC ROIC Metrics

ATRC Return on Assets Metrics

ATRC Return on Equity Metrics

ATRC Net Profit Margin Metrics

ATRC Gross Profit Margin Metrics

ATRC Tax Rate Metrics

PS Ratio	4.86
PS Ratio Avg TTM	3.24
PS Ratio Avg 3Y	3.39
Current VS TTM Avg	+49.99%
Current VS 3Y Avg	+43.42%
Current VS 5Y Avg	+5.76%

PB Ratio	5.36
PB Ratio Avg TTM	3.54
PB Ratio Avg 3Y	3.28
Current VS TTM Avg	+51.56%
Current VS 3Y Avg	+63.17%
Current VS 5Y Avg	+38.65%

PFCF Ratio	53.93
PFCF Ratio Avg TTM	72.35
PFCF Ratio Avg 3Y	93.08
Current VS TTM Avg	-25.46%
Current VS 3Y Avg	-42.06%
Current VS 5Y Avg	-42.06%

Debt/Equity Ratio	0.14
Debt/Equity Ratio Avg TTM	0.16
Debt/Equity Ratio Avg 3Y	0.16
Current VS TTM Avg	-13.61%
Current VS 3Y Avg	-16.11%
Current VS 5Y Avg	-15.92%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	1.85%
FCF Yield Avg TTM	2.05%
FCF Yield Avg 3Y	1.80%
Current VS TTM Avg	-9.55%
Current VS 3Y Avg	+2.56%
Current VS 5Y Avg	+2.56%

Earnings Yield	0.38%
Earnings Yield Avg TTM	0.43%
Earnings Yield Avg 3Y	0.43%
Current VS TTM Avg	-12.54%
Current VS 3Y Avg	-12.54%
Current VS 5Y Avg	-79.36%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	192.27
Ev/Ebit Ratio Avg TTM	169.00
Ev/Ebit Ratio Avg 3Y	169.00
Current VS TTM Avg	+13.77%
Current VS 3Y Avg	+13.77%
Current VS 5Y Avg	+13.77%

Ev/Ebitda Ratio	76.86
Ev/Ebitda Ratio Avg TTM	85.01
Ev/Ebitda Ratio Avg 3Y	85.01
Current VS TTM Avg	-9.59%
Current VS 3Y Avg	-9.59%
Current VS 5Y Avg	-9.59%

Ev/Assets Ratio	3.95
Ev/Assets Ratio Avg TTM	2.54
Ev/Assets Ratio Avg 3Y	2.45
Current VS TTM Avg	+55.34%
Current VS 3Y Avg	+61.02%
Current VS 5Y Avg	+31.93%

Ev/Sales Ratio	4.69
Ev/Sales Ratio Avg TTM	3.12
Ev/Sales Ratio Avg 3Y	3.30
Current VS TTM Avg	+50.54%
Current VS 3Y Avg	+42.20%
Current VS 5Y Avg	+2.51%

Current Ratio	4.22
Current Ratio Avg TTM	4.05
Current Ratio Avg 3Y	3.83
Current VS TTM Avg	+4.05%
Current VS 3Y Avg	+10.24%
Current VS 5Y Avg	+11.56%

Quick Ratio	3.19
Quick Ratio Avg TTM	3.01
Quick Ratio Avg 3Y	2.80
Current VS TTM Avg	+6.10%
Current VS 3Y Avg	+13.96%
Current VS 5Y Avg	+11.96%

ROIC	2.04%
ROIC Avg 3Y	(5.37%)
ROIC Avg 5Y	(6.49%)
Current VS 3Y Avg	+137.98%
Current VS 5Y Avg	+131.41%
Current VS 10Y Avg	+126.90%

ROA	1.56%
ROA Avg TTM	0.11%
ROA Avg 3Y	(0.92%)
Current VS TTM Avg	+1318.30%
Current VS 3Y Avg	+269.42%
Current VS 5Y Avg	+221.99%

ROE	2.04%
ROE Avg TTM	(3.02%)
ROE Avg 3Y	(6.53%)
Current VS TTM Avg	+167.62%
Current VS 3Y Avg	+131.23%
Current VS 5Y Avg	+132.58%

Net Profit Margin	1.85%
Net Profit Margin Avg TTM	0.48%
Net Profit Margin Avg 3Y	(4.99%)
Current VS TTM Avg	+283.73%
Current VS 3Y Avg	+137.06%
Current VS 5Y Avg	+121.67%

Gross Profit Margin	76.16%
Gross Pft Margin Avg TTM	75.81%
Gross Pft Margin Avg 3Y	74.78%
Current VS TTM Avg	+0.46%
Current VS 3Y Avg	+1.85%
Current VS 5Y Avg	+1.92%

Tax Rate	5.00%
Tax Rate Avg 3Y	34.39%
Tax Rate Avg 5Y	25.80%
Current VS 3Y Avg	-85.47%
Current VS 5Y Avg	-80.64%
Current VS 10Y Avg	-80.64%